VA Med/Jonathan M Wainwright Mem SARRTP/PRRTP and Outpt Trt

VA Med/Jonathan M Wainwright Mem SARRTP/PRRTP and Outpt Trt

Services:
Facility Smoking Policy
• Smoking not permitted

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Testing

• HIV testing
• Drug or alcohol urine screening
• STD testing
• Breathalyzer or blood alcohol testing
• Metabolic syndrome monitoring
• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• TB screening

Payment Assistance Available

• Payment assistance (check with facility for details)

Treatment Approaches

• Motivational interviewing
• Relapse prevention
• Telemedicine/telehealth therapy
• Trauma-related counseling
• Cognitive behavioral therapy
• Substance use disorder counseling
• Anger management

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Type of Opioid Treatment

• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Prescribes naltrexone
• Buprenorphine maintenance

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

License/Certification/Accreditation

• Commission on Accreditation of Rehabilitation Facilities (CARF)
• The Joint Commission

Facility Operation (e.g., Private, Public)

• U.S. Department of Veterans Affairs
• Federal Government

Recovery Support Services

• Housing services
• Assistance with obtaining social services
• Mentoring/peer support
• Employment counseling or training
• Self-help groups

Assessment/Pre-treatment

• Comprehensive mental health assessment
• Screening for tobacco use
• Complete medical history/physical exam
• Professional interventionist/educational consultant
• Interim services for clients
• Screening for mental disorders
• Screening for substance use
• Comprehensive substance use assessment

Special Programs/Groups Offered

• Veterans

Pharmacotherapies

• Medication for mental disorders
• Acamprosate (Campral®)
• Naltrexone (oral)
• Medications for Hepatitis C treatment
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Non-nicotine smoking/tobacco cessation
• Naltrexone (extended-release, injectable)
• Disulfiram
• Medications for HIV treatment
• Nicotine replacement
• Clonidine

Facility Vaping Policy

• Vaping not permitted

Language Services

• Sign language services for the deaf and hard of hearing

Education and Counseling Services

• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
• Individual counseling
• Smoking/vaping/tobacco cessation counseling
• Health education services other than HIV/AIDS or hepatitis
• Marital/couples counseling
• Group counseling
• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Family counseling
• Hepatitis education, counseling, or support

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Short-term residential
• Residential/24-hour residential
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment

Gender Accepted

• Male
• Female

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Age Groups Accepted

• Young Adults
• Adults

Ancillary Services

• Case management service
• Transportation assistance
• Social skills development
• Acupuncture
• Integrated primary care services
• Mental health services
• Domestic violence services, including family or partner
• Early intervention for HIV
• Suicide prevention services

Payment/Insurance/Funding Accepted

• Private health insurance
• Medicare
• Federal, or any government funding for substance use treatment programs
• Federal military insurance (e.g., TRICARE)
• Cash or self-payment

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity